CA2303505C - Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene - Google Patents

Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene Download PDF

Info

Publication number
CA2303505C
CA2303505C CA 2303505 CA2303505A CA2303505C CA 2303505 C CA2303505 C CA 2303505C CA 2303505 CA2303505 CA 2303505 CA 2303505 A CA2303505 A CA 2303505A CA 2303505 C CA2303505 C CA 2303505C
Authority
CA
Canada
Prior art keywords
lapase
monoclonal antibody
antibody
cells
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2303505
Other languages
English (en)
Other versions
CA2303505A1 (fr
Inventor
Gabriel Pulido-Cejudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canada Minister of Health
Original Assignee
Canada Minister of Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002267481A external-priority patent/CA2267481A1/fr
Application filed by Canada Minister of Health filed Critical Canada Minister of Health
Priority to CA 2303505 priority Critical patent/CA2303505C/fr
Publication of CA2303505A1 publication Critical patent/CA2303505A1/fr
Application granted granted Critical
Publication of CA2303505C publication Critical patent/CA2303505C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
CA 2303505 1999-03-30 2000-03-30 Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene Expired - Fee Related CA2303505C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2303505 CA2303505C (fr) 1999-03-30 2000-03-30 Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,267,481 1999-03-30
CA002267481A CA2267481A1 (fr) 1999-03-30 1999-03-30 Interdependance critique : du role de l'oestrogene dans le cancer du sein a la sensibilite des femmes a l'infection par le vih
CA 2303505 CA2303505C (fr) 1999-03-30 2000-03-30 Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene

Publications (2)

Publication Number Publication Date
CA2303505A1 CA2303505A1 (fr) 2000-09-11
CA2303505C true CA2303505C (fr) 2001-11-13

Family

ID=25680864

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2303505 Expired - Fee Related CA2303505C (fr) 1999-03-30 2000-03-30 Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene

Country Status (1)

Country Link
CA (1) CA2303505C (fr)

Also Published As

Publication number Publication date
CA2303505A1 (fr) 2000-09-11

Similar Documents

Publication Publication Date Title
US6649743B1 (en) Monoclonal antibody against estrogen stimulated leucine aminopeptidase
US4536479A (en) Use of anti-idiotype antibodies in immunoassays
WO2016080701A1 (fr) Anticorps reconnaissant la nucléocapside du coronavirus du syndrome respiratoire du moyen-orient et utilisation de celui-ci
CA2008360A1 (fr) Essai immunologique pour le diagnostic de l'infarctus du myocarde
EP0741144B1 (fr) Anticorps monoclonal antiannexine-v, procede pour produire cet anticorps, et utilisation de cet anticorps
US6391634B1 (en) Monoclonal antibodies and their production and use
CN108780095A (zh) 利用简易免疫测定的癌胚纤连蛋白检测方法
JP4334065B2 (ja) 抗体のフレームワーク領域から誘導される物質によるイムノアッセイの干渉の減少
EP0381450B1 (fr) Essai pour la phosphatase alcaline de l'os
CN108700587A (zh) 利用免疫色谱法检测癌胚纤连蛋白的方法
JPH08311100A (ja) ヒト肺腺癌に関するモノクローナル抗体および抗原、及びそれを用いた免疫測定方法
CA2303505C (fr) Anticorps monoclonal anti-leucine aminopeptidase stimulee par l'oestrogene
JPH0580053A (ja) ヒト子宮体癌細胞の免疫化学的検出方法
CA2303598C (fr) Dosage immunologique en tandem pour diagnostiquer le cancer
US5312900A (en) 23K protein with binding specificity for queuine
CA1286606C (fr) Methode de dosage des antigenes d'adenocarcinomes
JPS60171461A (ja) アミラ−ゼを用いた抗原決定基具有物質測定法
CN115651914A (zh) 杂交瘤细胞、单克隆抗体和p4hb蛋白检测试剂
JPH0643167A (ja) 癌マーカーであるテネイシン及びその定量法
US20190302124A1 (en) Compositions and Methods for Identifying Subjects Who May Benefit From Treatment With Therapeutic Agents
CN118515772A (zh) 抗生物素单克隆抗体及其制备方法和应用
Vengerov et al. Immunochemical studies of human placental alkaline phosphatase in normal and neoplastic tissues
JP2001343389A (ja) Ｍｄｍ２に対する自己抗体の測定によるがんの検査方法およびその試薬
KR20200049388A (ko) 페스트균의 f1 캡슐 단백질에 특이적으로 결합하는 단일클론항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
JPH06242109A (ja) コラーゲンの測定方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed